These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1501535)

  • 21. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical properties, pharmacokinetics, and biodistribution of gadoteridol injection in rats and dogs.
    Eakins MN; Eaton SM; Fisco RA; Hunt RJ; Ita CE; Katona T; Owies LM; Schramm E; Sulner JW; Thompson CW
    Acad Radiol; 1995 Jul; 2(7):584-91. PubMed ID: 9419608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
    Krause W; Schuhmann-Giampieri G; Bauer M; Press WR; Muschick P
    Invest Radiol; 1996 Aug; 31(8):502-11. PubMed ID: 8854197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G
    Arzneimittelforschung; 1993 Sep; 43(9):1020-4. PubMed ID: 8240452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents.
    Erdene K; Nakajima T; Kameo S; Khairinisa MA; Lamid-Ochir O; Tumenjargal A; Koibuchi N; Koyama H; Tsushima Y
    Jpn J Radiol; 2017 Oct; 35(10):568-573. PubMed ID: 28730467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of excess gadolinium into human bone from medical contrast agents.
    Darrah TH; Prutsman-Pfeiffer JJ; Poreda RJ; Ellen Campbell M; Hauschka PV; Hannigan RE
    Metallomics; 2009 Nov; 1(6):479-88. PubMed ID: 21305156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism.
    Morris TW; Ekholm SE; Prentice LI
    Invest Radiol; 1991 Dec; 26(12):1087-90. PubMed ID: 1765443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
    Berkowitz BA; Sato Y; Wilson CA; de Juan E
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
    Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
    Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
    McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
    Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solvate structures in water-methanol solutions of MRI contrast agents: electron spin echo envelope modulation in gadolinium chelates.
    Clarkson RB; Hwang JH; Belford RL
    Magn Reson Med; 1993 Apr; 29(4):521-7. PubMed ID: 8385260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.
    Donahue KM; Burstein D; Manning WJ; Gray ML
    Magn Reson Med; 1994 Jul; 32(1):66-76. PubMed ID: 8084239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans.
    Schuhmann-Giampieri G; Mahler M; Röll G; Maibauer R; Schmitz S
    J Clin Pharmacol; 1997 Jul; 37(7):587-96. PubMed ID: 9243351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clearance of gadolinium chelates by hemodialysis: an in vitro study.
    Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA
    J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.